Search Videos and More
Study: Counting Cancerous Lymph Nodes Is Best Predictor
Cedars-Sinai Researchers Discover Lymph Node Count Is Best Predictor of Mortality Across Nearly All CancersSix Questions With Ophir Klein, MD, PhD
Ophir Klein, MD, PhD, aims to establish Cedars-Sinai as a destination for children and their families in the Los Angeles community and beyond. Klein, the David and Meredith Kaplan Distinguished Chair in Children’s Health, is the inaugural executive director of Cedars-Sinai Guerin Children’s, a new initiative that will offer the full spectrum of pediatric specialties as well as a robust research program and training for future pediatricians. Guerin Children's has been made possible by the generosity of the Shapell Guerin Family Foundation and its president, Vera Guerin, a longtime Cedars-Sinai supporter who is the immediate past board chair of Cedars-Sinai Health System. We asked Klein what the future of pediatrics might look like.Scientists Discover Gene Plays Critical Role in Embryo Development
Study Co-Led by Cedars-Sinai Investigator Suggests Mutations in the Gene Cnpy4 Could Cause a Birth Defect Involving Extra Fingers or ToesNew Technique Can Make Lung Surgery More Accessible
New techniques are making lung transplants more accessible to more patients through minimally invasive and robotically assisted techniques. Learn more.Biologic Solutions to Arthritis in Upper Extremities
Humans are living longer than ever before. While that comes with a lot of advantages, it also means many people will eventually suffer from arthritis.Cedars-Sinai Offers Program to Catch Older Adults Before They Fall
During Osteoporosis Awareness Month, at-risk adults are encouraged to get bone density checked and falls risk assessed.Pioneers in Medicine with Dr. Bruce Gewertz
In our “Pioneers in Medicine” series, Dr. Bruce Gewertz speaks with Cedars-Sinai experts that are innovating medicine.Cedars-Sinai Gifted $10M to Create Memory and Aging Program
Donation from Maxine Platzer Lynn will advance memory and healthy aging care at Cedars-Sinai.Study: Antibody Response Varies by Tumor Type and Treatment
Dual studies by Cedars-Sinai Cancer researchers have found that there are significant differences in the durability of antibody responses and frequency of breakthrough cases in patients who are undergoing cancer treatments and receive certain COVID-19 vaccinations.Pioneers in Medicine with Dr. Bruce Gewertz: Recognizing the Risk of Pulmonary Embolism
In this “Pioneers in Medicine” episode, Tapson talks more about the patient population, risks and treatment options in an episode of Pioneers in Medicine.Pioneers in Medicine with Dr. Bruce Gewertz: The Mysterious Causes of Pulmonary Fibrosis
Paul Noble, MD, Distinguished Professor and Chair of Medicine, continues the Pioneers in Medicine series with more on this mystery and what’s being done to solve it.Pioneers in Medicine with Dr. Gewertz: Specialized Care for Brain Tumors Drives Quality Outcomes
In this “Pioneers in Medicine” episode, Keith Black, MD, shares how he built an expert team of neurosurgeons who drive this idea forward, subspecializing in particular tumors to make sure patients receive the highest quality care and achieve the best outcomes possible.